EICHORCondition: Transthyretin (TTR) Amyloid Cardiomyopathy · Sponsor: Yale University
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multi-center, observational study with the overall objective to examine the scale of under-diagnosis for transthyretin amyloid cardiomyopathy (ATTR-CM) across a broad range of diverse health systems in the US using a fully federated deployment of an artificial intelligence (AI) toolkit of algorithms that detect ATTR-CM on electrocardiography (ECG), point-of-care ultrasound (POCUS), and transthoracic echocardiography (TTE).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of California - San Francisco (UCSF) Health | San Francisco, California, United States | — |
| Yale New Haven Health System | New Haven, Connecticut, United States | — |
| The University of Chicago | Chicago, Illinois, United States | — |
| Henry Ford Health | Detroit, Michigan, United States | — |
| Mount Sinai | New York, New York, United States | — |
| Montefiore | The Bronx, New York, United States | — |
| Providence Health | Tigard, Oregon, United States | — |
| Medical University of South Carolina (MUSC) Health | Charleston, South Carolina, United States | — |
| UT Southwestern Medical Center | Dallas, Texas, United States | — |
| Houstin Methodist | Houston, Texas, United States | — |
| University of Virginia School of Medicine | Charlottesville, Virginia, United States | — |
| University of Washington Medicine | Seattle, Washington, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07062848